{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:31:46Z","timestamp":1770741106167,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>National Comprehensive Cancer Network (NCCN) melanoma treatment guidelines are based on best available literature. We evaluated NCCN excision margin and sentinel lymph node biopsy (SLNB) guideline adherence to identify patient populations at risk for suboptimal care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective review of prospectively maintained database of all patients who underwent operation for invasive melanoma from January 2005 to 2015.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 865 patients underwent operation for 522 thin (60.3%), 268 intermediate-thickness (31.0%), and 75 thick (8.7%) melanomas. Tumor location was 349 extremity (40.4%), 348 trunk (40.2%), and 168 head\/neck (19.4%). SLNB was performed in 422 patients (48.8%); 75 (17.8%) were positive, and 67 (15.9%) underwent therapeutic lymphadenectomy. A total of 154 lesions (17.8%) were ulcerated; 444 had mitotic rate \u22651 (51.3%). In total, 788 patients (91.1%) fulfilled both NCCN guidelines. Recommended surgical margins were achieved in 837 patients (96.8%) and SLNB was performed as appropriate in 806 patients (93.2%); 10 patients (1.2%) were deficient for both. Deficient margins and lack of SLNB were associated with increased invasion depth and head\/neck location; deficient SLNB was associated with age 80 and above (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). Overall recurrence was 7.1%: 15 local (1.7%), 23 regional (2.7%), and 23 distant (2.7%) failures. Local recurrence was associated with head\/neck location (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.031); all recurrence types were associated with increased tumor thickness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>NCCN excision and SLNB guidelines were almost always met. Patients at risk for not meeting criteria included the elderly and those with head\/neck tumors. Failure to meet NCCN criteria was not associated with increased disease recurrence. Surgeons must carefully balance the risks of not pursuing NCCN guidelines with treatment goals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000362","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T17:39:42Z","timestamp":1485279582000},"page":"754-759","source":"Crossref","is-referenced-by-count":17,"title":["Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines"],"prefix":"10.1097","volume":"41","author":[{"given":"Andrew M.","family":"Blakely","sequence":"first","affiliation":[{"name":"Department of Surgery, Rhode Island Hospital"},{"name":"Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle S.","family":"Comissiong","sequence":"additional","affiliation":[{"name":"Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Vezeridis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rhode Island Hospital"},{"name":"Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Miner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rhode Island Hospital"},{"name":"Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"666","DOI":"10.6004\/jnccn.2006.0057","article-title":"Melanoma","volume":"4","author":"Houghton","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6004\/jnccn.2009.0020","article-title":"Melanoma","volume":"7","author":"Coit","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1245\/s10434-008-0021-0","article-title":"Adverse outcomes associated with noncompliance with melanoma treatment guidelines","volume":"15","author":"Erickson Foster","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CMR.0b013e32836254bd","article-title":"Compliance with guidelines in the surgical management of cutaneous melanoma across the USA","volume":"23","author":"Wasif","year":"2013","journal-title":"Melanoma Res"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1245\/ASO.2004.03.044","article-title":"Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model","volume":"11","author":"Sondak","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","article-title":"The prognostic importance of sentinel lymph node biopsy in thin melanoma","volume":"13","author":"Ranieri","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"308","DOI":"10.6004\/jnccn.2009.0023","article-title":"Role of sentinel lymph node biopsy in patients with thin melanoma","volume":"7","author":"Andtbacka","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archsurg.1991.01410280036004","article-title":"Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma","volume":"126","author":"Veronesi","year":"1991","journal-title":"Arch Surg"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","article-title":"Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial","volume":"218","author":"Balch","year":"1993","journal-title":"Ann Surg"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1245\/s10434-012-2543-8","article-title":"1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival?","volume":"20","author":"Hudson","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1245\/s10434-015-4575-3","article-title":"Minimum safe pathologic excision margins for primary cutaneous melanomas (1-2 mm in thickness): analysis of 2131 patients treated at a single center","volume":"23","author":"Haydu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"621","DOI":"10.6004\/jnccn.2014.0066","article-title":"Melanoma, version 4.2014","volume":"12","author":"Coit","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","article-title":"The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)","volume":"17","author":"Faries","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-I, an International Multicenter Trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"177","DOI":"10.6004\/jnccn.2015.0026","article-title":"Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting","volume":"13","author":"Adegboyega","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1477-2574.2012.00496.x","article-title":"Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes","volume":"14","author":"Visser","year":"2012","journal-title":"HPB (Oxford)"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"319","DOI":"10.6004\/jnccn.2015.0044","article-title":"Compliance with gastric cancer guidelines is associated with improved outcomes","volume":"13","author":"Worhunsky","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/djt065","article-title":"Disparities in ovarian cancer care quality and survival according to race and socioeconomic status","volume":"105","author":"Bristow","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1245\/s10434-007-9789-6","article-title":"Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables","volume":"15","author":"Erickson","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"204","DOI":"10.6004\/jnccn.2014.0021","article-title":"Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons","volume":"12","author":"Jagsi","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1200\/JCO.2005.21.360","article-title":"Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy","volume":"23","author":"Cormier","year":"2005","journal-title":"J Clin Oncol"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1245\/ASO.2004.04.015","article-title":"Correlation between prognostic factors and increasing age in melanoma","volume":"11","author":"Chao","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.2008.18.7567","article-title":"Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J Clin Oncol"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrclinonc.2010.1","article-title":"Epidemiology and treatment of melanoma in elderly patients","volume":"7","author":"Tsai","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-012-2826-0","article-title":"Sentinel node biopsy in thin and thick melanoma","volume":"20","author":"Mozzillo","year":"2013","journal-title":"Ann Surg Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:06:17Z","timestamp":1693710377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00005"}},"subtitle":["Who Is at Risk?"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000362","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}